These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19863866)

  • 1. Hypertension and diastolic heart failure.
    Gradman AH; Wilson JT
    Curr Cardiol Rep; 2009 Nov; 11(6):422-9. PubMed ID: 19863866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Impact of Left Ventricular Diastolic Dysfunction in Chronic Kidney Disease.
    Ogawa T; Nitta K
    Contrib Nephrol; 2018; 195():81-91. PubMed ID: 29734153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension and cardiac failure in its various forms.
    Gaddam KK; Verma A; Thompson M; Amin R; Ventura H
    Med Clin North Am; 2009 May; 93(3):665-80. PubMed ID: 19427498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical management of mild-to-moderate heart failure before the advent of beta blockers.
    Abraham WT; Wagoner LE
    Am J Med; 2001 May; 110 Suppl 7A():47S-62S. PubMed ID: 11334776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.
    Garcia AG; Wilson RM; Heo J; Murthy NR; Baid S; Ouchi N; Sam F
    Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H587-96. PubMed ID: 22730392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological basis of antihypertensive drug therapy].
    Kolck UW; Zaugg CE; Erne P
    Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy for hypertension associated with heart failure].
    Miyamoto H; Imaizumi T
    Nihon Naika Gakkai Zasshi; 2003 Feb; 92(2):258-63. PubMed ID: 12652730
    [No Abstract]   [Full Text] [Related]  

  • 9. From hypertension to heart failure.
    Papademetriou V
    J Clin Hypertens (Greenwich); 2004 Oct; 6(10 Suppl 2):14-7. PubMed ID: 15470294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.
    Schmieder RE; Martus P; Klingbeil A
    JAMA; 1996 May; 275(19):1507-13. PubMed ID: 8622227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.
    Gradman AH; Alfayoumi F
    Prog Cardiovasc Dis; 2006; 48(5):326-41. PubMed ID: 16627048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update in pharmacologic treatment of hypertension.
    Ferdinand KC
    Cardiol Clin; 2001 May; 19(2):279-94, v. PubMed ID: 11407110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical repair of hypertensive left ventricular remodeling.
    Motz WH; Scheler S; Strauer BE
    J Cardiovasc Pharmacol; 1992; 20 Suppl 1():S32-6. PubMed ID: 1380616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology and clinical aspects of hypertensive hypertrophy.
    Vogt M; Motz WH; Schwartzkopf B; Strauer BE
    Eur Heart J; 1993 Jul; 14 Suppl D():2-7. PubMed ID: 8103741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996).
    Schmieder RE; Schlaich MP; Klingbeil AU; Martus P
    Nephrol Dial Transplant; 1998 Mar; 13(3):564-9. PubMed ID: 9550628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hypertension in heart failure with preserved ejection fraction: role of the kidney.
    Shinde AA; Anderson AS
    Heart Fail Clin; 2008 Oct; 4(4):479-503. PubMed ID: 18760759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arterial hypertension and systolic left ventricular dysfunction: therapeutic approach].
    Anguita Sánchez M
    Rev Esp Cardiol; 1999; 52 Suppl 3():34-8. PubMed ID: 10614147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arterial hypertension and cardiac decompensation].
    Degaute JP
    Rev Med Brux; 1996 Sep; 17(4):272-4. PubMed ID: 8927860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of diastolic dysfunction in hypertension.
    Ginelli P; Bella JN
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):613-8. PubMed ID: 22743209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.